UnitedHealth Group Incorporated (UNH)
NYSE: UNH · Real-Time Price · USD
513.45
-3.05 (-0.59%)
Mar 25, 2025, 4:00 PM EST - Market closed
UnitedHealth Group Stock Forecast
Stock Price Forecast
The 20 analysts with 12-month price forecasts for UnitedHealth Group stock have an average target of 623.6, with a low estimate of 460 and a high estimate of 700. The average target predicts an increase of 21.45% from the current stock price of 513.45.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jan 28, 2025.
Analyst Ratings
The average analyst rating for UnitedHealth Group stock from 20 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Buy | 11 | 11 | 11 | 12 | 12 | 12 |
| Hold | 2 | 2 | 2 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 20 | 20 | 20 | 21 | 21 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $694 → $660 | Buy | Maintains | $694 → $660 | +28.54% | Jan 28, 2025 |
| Barclays | Barclays | Buy Maintains $655 → $642 | Buy | Maintains | $655 → $642 | +25.04% | Jan 17, 2025 |
| Keybanc | Keybanc | Buy Reiterates $650 | Buy | Reiterates | $650 | +26.59% | Jan 17, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $700 | Buy | Reiterates | $700 | +36.33% | Jan 17, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $625 → $610 | Strong Buy | Maintains | $625 → $610 | +18.80% | Jan 6, 2025 |
Financial Forecast
Revenue This Year
454.62B
from 400.28B
Increased by 13.58%
Revenue Next Year
490.85B
from 454.62B
Increased by 7.97%
EPS This Year
30.03
from 15.51
Increased by 93.61%
EPS Next Year
33.84
from 30.03
Increased by 12.69%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 480.3B | 523.5B | 575.4B | ||
| Avg | 454.6B | 490.8B | 531.0B | ||
| Low | 419.6B | 452.5B | 491.8B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 20.0% | 15.2% | 17.2% | ||
| Avg | 13.6% | 8.0% | 8.2% | ||
| Low | 4.8% | -0.5% | 0.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 31.73 | 36.00 | 41.63 | ||
| Avg | 30.03 | 33.84 | 38.44 | ||
| Low | 28.67 | 31.38 | 34.66 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 104.6% | 19.9% | 23.0% | ||
| Avg | 93.6% | 12.7% | 13.6% | ||
| Low | 84.8% | 4.5% | 2.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.